Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Vitamin A  COVID-19 treatment studies for Vitamin A  C19 studies: Vitamin A  Vitamin A   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
The Impact of Severe COVID-19 on Plasma Antioxidants
Žarković et al., Molecules, doi:10.3390/molecules27165323
Žarković et al., The Impact of Severe COVID-19 on Plasma Antioxidants, Molecules, doi:10.3390/molecules27165323
Aug 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective 88 COVID-19 patients and 33 healthy controls, showing significantly lower vitamin A levels in COVID-19 patients vs. healthy controls, and in patients that did not survive vs. survivors. Patient ages were significantly different between groups.
Žarković et al., 21 Aug 2022, Croatia, peer-reviewed, 10 authors.
Contact: zarkovic@irb.hr (corresponding author).
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin AAll
Abstract: molecules Article The Impact of Severe COVID-19 on Plasma Antioxidants Neven Žarković 1, * , Anna Jastrzab ˛ 2 , Iwona Jarocka-Karpowicz 2 , Biserka Orehovec 3 , Bruno Baršić 4 , 5 3 Marko Tarle , Marta Kmet , Ivica Lukšić 5,6 , Wojciech Łuczaj 2 and Elżbieta Skrzydlewska 2 1 2 3 4 5 6 * Citation: Žarković, N.; Jastrzab, ˛ A.; Jarocka-Karpowicz, I.; Orehovec, B.; Baršić, B.; Tarle, M.; Kmet, M.; Lukšić, I.; Łuczaj, W.; Skrzydlewska, E. The Laboratory for Oxidative Stress (LabOS), Rud̄er Bošković Institute, HR-10000 Zagreb, Croatia Department of Analytical Chemistry, Medical University of Bialystok, 15-089 Bialystok, Poland Clinical Department of Laboratory Diagnostics, Clinical Hospital Dubrava, HR-10000 Zagreb, Croatia Department of Internal Medicine, Clinical Hospital Dubrava, HR-10000 Zagreb, Croatia Department of Maxillofacial Surgery, Clinical Hospital Dubrava, HR-10000 Zagreb, Croatia School of Medicine, University of Zagreb, HR-10000 Zagreb, Croatia Correspondence: zarkovic@irb.hr Abstract: Several studies suggested the association of COVID-19 with systemic oxidative stress, in particular with lipid peroxidation and vascular stress. Therefore, this study aimed to evaluate the antioxidant signaling in the plasma of eighty-eight patients upon admission to the Clinical Hospital Dubrava in Zagreb, of which twenty-two died within a week, while the other recovered. The differences between the deceased and the survivors were found, especially in the reduction of superoxide dismutases (SOD-1 and SOD-2) activity, which was accompanied by the alteration in glutathione-dependent system and the intensification of the thioredoxin-dependent system. Reduced levels of non-enzymatic antioxidants, especially tocopherol, were also observed, which correlated with enhanced lipid peroxidation (determined by 4-hydroxynonenal (4-HNE) and neuroprostane levels) and oxidative modifications of proteins assessed as 4-HNE-protein adducts and carbonyl groups. These findings confirm the onset of systemic oxidative stress in patients with severe SARSCoV-2, especially those who died from COVID-19, as manifested by strongly reduced tocopherol level and SOD activity associated with lipid peroxidation. Therefore, we propose that preventive and/or supplementary use of antioxidants, especially of lipophilic nature, could be beneficial for the treatment of COVID-19 patients. Impact of Severe COVID-19 on Plasma Antioxidants. Molecules 2022, 27, 5323. https://doi.org/10.3390/ Keywords: COVID-19; SARS-CoV-2; biomarkers; plasma; antioxidants; GSH system; Trx system; lipid peroxidation; 4-HNE-protein adducts molecules27165323 Academic Editor: Jean-Marc Sabatier Received: 19 July 2022
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit